Cleared Traditional

K223013 - AccurECG Analysis System

K223013 is an FDA 510(k) clearance for AccurECG Analysis System, manufactured by Accurkardia, Inc.. The device is a Class 2 Cardiovascular device with product code DPS cleared through the Traditional 510(k) pathway after a 267-day FDA review.

K223013 · Accurkardia, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2023
Decision
267d
Days
Class 2
Risk

K223013 is an FDA 510(k) clearance for the AccurECG Analysis System. Classified as Electrocardiograph (product code DPS), Class II - Special Controls.

Submitted by Accurkardia, Inc. (New York, US). The FDA issued a Cleared decision on June 23, 2023 after a review of 267 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2340 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Accurkardia, Inc. devices

FDA 510(k) Submission Details - K223013

510(k) Number K223013 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 29, 2022
Decision Date June 23, 2023
Days to Decision 267 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
142d slower than avg
Panel avg: 125d · This submission: 267d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DPS Device Classification - Class 2, Special Controls

Product Code DPS Electrocardiograph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2340
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

Hyman, Phelps & McNamara, P.C.
Kwame Ulmer

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - DPS Electrocardiograph

All 279
Devices cleared under the same product code (DPS) and FDA review panel - the closest regulatory comparables to K223013.
Withings Scan Monitor 2.0
K230812 · Withings · Aug 2023
Electrocardiograph: SE-1200 Pro and SE-1201 Pro
K222902 · Edan Instruments, Inc. · Jul 2023
MESI mTablet ECG Diagnostic System, MESI mTablet ECG
K223670 · Mesi, Development of Medical Devices, Ltd.; Mesi D.O.O. · Jul 2023
CSF-3
K221260 · Cardiacsense · Jan 2023
PageWriter TC35 Cardiograph
K221141 · Medizin Systeme Boblingen GmbH · Dec 2022
Cardio10
K220535 · Bionet Co., Ltd. · Nov 2022